Results of a Dana-Farber Cancer Institute-initiated phase 1 clinical trial for patients with melanoma show that an updated ...

Results of a Dana-Farber Cancer Institute-initiated phase 1 clinical trial for patients with melanoma show that an updated formula and delivery of the NeoVax personalized cancer vaccine called ...

A breast cancer vaccine targeting a key protein showed strong immune responses in over 75 percent of its trial participants ...

A new breast cancer vaccine shows significant promise in preventing and treating the disease, particularly triple-negative ...

Trump administration policy tug-of-war between big medical groups that want COVID vaccines back on CDC schedule for healthy ...

Passion is an important word in Georgina Long’s lexicon. It’s the drive that has stamped her as an internationally renowned ...

Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that the United States Patent and ...

In this episode presented by Eclipsebio, BioSpace's head of insights Lori Ellis discusses mRNA and srRNA with Andy Geall of Replicate Bioscience and Alliance for mRNA Medicines, and Pad Chivukula of ...

The mRNA drug developer said it will begin discussing approval with the FDA, which has adopted stricter vaccine review ...